# Oxytocin MEG Study

> **NCT02568709** · EARLY_PHASE1 · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 40 (actual)

## Conditions studied

- Schizophrenia
- Oxytocin
- Magnetoencephalography (MEG)
- Social Cognition

## Interventions

- **DRUG:** Oxytocin
- **DRUG:** Saline Nasal Spray

## Key facts

- **NCT ID:** NCT02568709
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-02
- **Primary completion:** 2016-12
- **Final completion:** 2016-12
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2019-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02568709

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02568709, "Oxytocin MEG Study". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02568709. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*